CAS 265312-55-8
:2-methyl-5-[(4-methylphenyl)amino]-1,3-benzothiazole-4,7-dione
Description:
2-Methyl-5-[(4-methylphenyl)amino]-1,3-benzothiazole-4,7-dione, with the CAS number 265312-55-8, is a synthetic organic compound characterized by its complex structure that includes a benzothiazole core. This compound features a methyl group and an amino group attached to the benzothiazole ring, contributing to its chemical reactivity and potential biological activity. The presence of the 4-methylphenyl group enhances its lipophilicity, which may influence its solubility and interaction with biological membranes. Typically, compounds of this nature may exhibit properties such as fluorescence, making them useful in various applications, including as dyes or in medicinal chemistry. The specific functional groups present suggest potential for interactions with biological targets, which could be explored for therapeutic applications. Additionally, the compound's stability and reactivity can be influenced by environmental factors such as pH and temperature, which are important considerations in both laboratory and industrial settings. Overall, this compound represents a class of organic molecules with diverse applications in research and industry.
Formula:C15H12N2O2S
InChI:InChI=1/C15H12N2O2S/c1-8-3-5-10(6-4-8)17-11-7-12(18)15-13(14(11)19)16-9(2)20-15/h3-7,17H,1-2H3
SMILES:Cc1ccc(cc1)NC1=CC(=O)c2c(C1=O)nc(C)s2
Synonyms:- 2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione
- 4,7-Benzothiazoledione, 2-methyl-5-[(4-methylphenyl)amino]-
- 2-Methyl-5-[(4-methylphenyl)amino]-1,3-benzothiazole-4,7-dione
- 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione
- Cdk4 Inhibitor III
- RYUVIDINE
- 2-METHYL-5-[(4-METHYLPHENYL)AMINO]-4,7-BENZOTHIAZOLEDIONE
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione
CAS:Formula:C15H12N2O2SPurity:98%Color and Shape:SolidMolecular weight:284.3330Cdk4 Inhibitor III
CAS:<p>Cdk4 Inhibitor III is a drug that inhibits the activity of cyclin-dependent kinase 4 (Cdk4) and plays an important role in cell cycle progression. Cdk4 is a protein kinase that phosphorylates other proteins, including p27Kip1, which has been shown to prevent the formation of new blood vessels. The inhibition of Cdk4 with this drug leads to an anti-angiogenic effect and can be used for the treatment of solid tumours. Clinical trials show that Cdk4 inhibitor III has limited effects on prostate cancer cells, but it is effective against cervical cancer cells and thymoma cells in vitro. The cytosolic Ca2+ concentration is reduced by Cdk4 inhibitor III, which may contribute to its clinical relevance as a cancer drug.</p>Formula:C15H12N2O2SPurity:Min. 95%Molecular weight:284.33 g/molRyuvidine
CAS:<p>Ryuvidine is a dual inhibitor of KDM5A and SETD8, an inducer of the DNA damage response, and can be used to study breast cancer and erythroderma.</p>Formula:C15H12N2O2SPurity:98.6%Color and Shape:SolidMolecular weight:284.33




